My Application Form Status

Check the status of your application form with Angel Broking.
NHPC gains after signing wind power purchase agreement in Rajasthan
Sep 30,2016

The announcement was made after market hours yesterday, 29 September 2016.

Meanwhile, the BSE Sensex was up 3.26 points, or 0.01%, to 27,830.79.

On BSE, so far 1.04 lakh shares were traded in the counter, compared with average daily volume of 5.33 lakh shares in the past one quarter. The stock hit a high of Rs 25.50 and a low of Rs 24.30 so far during the day. The stock hit a 52-week high of Rs 28.20 on 31 August 2016. The stock hit a 52-week low of Rs 16.55 on 1 October 2015. The stock had underperformed the market over the past 30 days till 29 September 2016, falling 13.37% compared with 2.20% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 2.61% as against Sensexs 2.51% rise.

The large-cap company has equity capital of Rs 11070.67 crore. Face value per share is Rs 10.

NHPC said that a wind power purchase agreement (PPA) has been signed amongst Rajasthan Government, NHPC and INOX on 28 September 2016 for 50 megawatts (MW) wind power project in Jaisalmer, Rajasthan. As per the PPA, Rajasthan Government will purchase the power generated from the project.

NHPCs net profit rose 7.5% to Rs 857.82 crore on 9.4% growth in net sales to Rs 2166.04 crore in Q1 June 2016 over Q1 June 2015.

NHPC was incorporated in the year 1975 with an objective to plan, promote and organise an integrated and efficient development of hydroelectric power in all aspects. Later on, NHPC expanded its objects to include development of power in all its aspects through conventional and non-conventional sources in India and abroad.

Government of India (GoI) currently holds 74.59% stake in NHPC (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

Alkem Laboratories slips after getting USFDA observations on Daman plant
Sep 30,2016

The announcement was made after market hours yesterday, 29 September 2016.

Meanwhile, the BSE Sensex was up 64.65 points, or 0.23%, to 27,892.18.

On BSE, so far 27,000 shares were traded in the counter, compared with average daily volume of 9,076 shares in the past one quarter. The stock hit a high of Rs 1,765.60 and a low of Rs 1,655 so far during the day. The stock hit a record high of Rs 1,852.95 on 29 September 2016. The stock hit a record low of Rs 1,175 on 2 May 2016. The stock had outperformed the market over the past 30 days till 29 September 2016, rising 16.67% compared with 2.20% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 32.06% as against Sensexs 2.51% rise.

The large-cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 2.

Alkem Laboratories said that US Food and Drug Administration (USFDA) had conducted an inspection at the companys manufacturing facility located at Daman, India from 20 September 2016 to 29 September 2016. In this regard, the company has received the inspection report which contains thirteen 483 observations. The company said it will put together a detailed response with adequate corrective and preventive measures to address the USFDA observations and the same is proposed to be filed within the timeline stipulated by USFDA.

On a consolidated basis, net profit of Alkem Laboratories rose 18.74% to Rs 238.79 crore on 20.34% rise in net sales to Rs 1439.36 crore in Q1 June 2016 over Q1 June 2015.

Alkem Laboratories is a pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Powered by Capital Market - Live News

Sintex Industries gains after announcing composite scheme of arrangement
Sep 30,2016

The announcement was made after market hours yesterday, 29 September 2016.

Meanwhile, the BSE Sensex was down 23.44 points, or 0.08%, to 27,804.09.

On BSE, so far 8.11 lakh shares were traded in the counter, compared with average daily volume of 9.09 lakh shares in the past one quarter. The stock hit a high of Rs 78.50 and a low of Rs 74.70 so far during the day. The stock hit a 52-week high of Rs 106.45 on 15 October 2015. The stock hit a 52-week low of Rs 62.36 on 12 February 2016. The stock had underperformed the market over the past 30 days till 29 September 2016, falling 2.67% compared with 2.20% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 11.36% as against Sensexs 2.51% rise.

The mid-cap company has equity capital of Rs 52.34 crore. Face value per share is Re 1.

Sintex Industries said that its board approved the composite scheme of arrangement for the demerger of the custom moulding business and the prefab business from Sintex Industries to Sintex-BAPL and Sintex Infra Projects, respectively, each a wholly owned subsidiary of Sintex Plastics Technology. The proposed arrangement will streamline various businesses developed by the group, thereby creating focused leadership and management attention. The scheme also involves issuance of equity shares of Sintex Plastics Technology to the equity shareholders of Sintex Industries such that shareholders of Sintex Industries will effectively get one equity share of Sintex Plastics Technology upon demergers against one equity share held in Sintex Industries and listing of these equity shares of Sintex Plastics Technology on the BSE and the NSE. The transaction is expected to unlock value of shareholders by separating various businesses in different entities.

Sintex Industries consolidated net profit rose 11.45% to Rs 76.03 crore on 16.48% growth in net sales to Rs 1695.25 crore in Q1 June 2016 over Q1 June 2015.

Sintex Industries is a dominant player in the plastics and textile business segments.

Powered by Capital Market - Live News

All 19 sectoral indices on BSE in red
Sep 29,2016

The S&P BSE Sensex was currently down 465.28 points, or 1.64% at 27,827.53.

The Indian Army conducted surgical strikes on terror launch pads yesterday, 28 September 2016 night across the Line of Control (LoC) in Pakistan, killing several terrorists and causing significant casualties to their hideouts. The press conference was jointly conducted by the Ministry of External Affairs and the Ministry of Defence. The Pakistani military reportedly said no such strike had taken place but that there had been an exchange of firing at the frontier.

All the 19 sectoral indices on BSE declined. The S&P BSE Realty index (down 6.31%), the S&P BSE Power index (down 4.11%), the S&P BSE Utilities index (down 3.49%), the S&P BSE Basic Materials index (down 3.48%), the S&P BSE Industrials index (down 3.29%) were the key sectoral indices losers.

Powered by Capital Market - Live News

ICICI Bank slips after weak debut of insurance subsidiary
Sep 29,2016

Meanwhile, the BSE Sensex was down 493.56 points, or 1.74%, to 27,799.25.

On BSE, so far 36.76 lakh shares were traded in the counter, compared with average daily volume of 13.65 lakh shares in the past one quarter. The stock hit a high of Rs 263.65 and a low of Rs 243.80 so far during the day. The stock hit a 52-week high of Rs 292.65 on 16 October 2015. The stock hit a 52-week low of Rs 180.80 on 26 February 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 1.82% compared with 0.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 8.58% as against Sensexs 4.79% rise.

The large-cap private sector bank has equity capital of Rs 1163.77 crore. Face value per share is Rs 2.

Shares of ICICI Prudential Life Insurance Company (ICICI Prudential) were trading at Rs 300.10 at 14:57 IST on BSE, a discount of 10.15% over the initial public offer (IPO) price of Rs 334. The stock debuted at Rs 329, a discount of 1.50% to the IPO price. So far the stock hit a high of Rs 333.90 and low of Rs 295.50.

The IPO comprised sale of up to 18.13 crore equity shares of ICICI Prudential, representing about 12.63% of its equity share capital for cash, through an offer for sale (OFS) by ICICI Bank. The entire proceeds from the OFS was paid to ICICI Bank.

ICICI Prudential is the largest private sector life insurer in India by total premium and assets under management at 31 March 2016. ICICI Prudential is a joint venture between ICICI Bank and Prudential Corporation Holdings, a part of the Prudential Group, an international financial services group. The company is one of the first private sector life insurance companies in India. It commenced operations in October 2000 and offers a range of life insurance, health insurance and pension products and services.

After the IPO, ICICI Banks stake in the subsidiary reduced to 54.89% from 67.52% earlier. Prudential Corporation Holdings held 25.83% stake in the company.

ICICI Banks net profit fell 25% to Rs 2232.35 crore on 6.1% increase in operating income to Rs 16759.51 crore in Q1 June 2016 over Q1 June 2015.

ICICI Bank is one of the leading private sector banks in India.

Powered by Capital Market - Live News

Small-Cap, Mid-Cap stocks slide
Sep 29,2016

Both these indices underperformed the barometer index, S&P BSE Sensex, which lost 512.64 points or 1.81% to 27,780.17. As per reports, the Indian Army conducted surgical strikes on terror launch pads yesterday, 28 September 2016 night across the Line of Control (LoC) in Pakistan, killing several terrorists and causing significant casualties to their hideouts.

The broad market depicted weakness. There were more than six losers against every gainer on BSE. 2,322 shares rose and 339 shares fell. A total of 180 shares were unchanged.

Top losers in the S&P BSE Mid-Cap index were Reliance Communications (down 9.21%), GMR Infrastructure (down 8.36%), Adani Enterprises (down 8.07%), Indian Bank (down 7.64%), Steel Authority of India (down 7.9%).

Top losers in the S&P BSE Small-Cap index were Signet Industries (down 20%), Morepen Laboratories (down 16.89%), Sarda Energy & Minerals (down 12.93%), Prakash Industries (down 13.68%) and Orchid Pharma (down 14.38%).

Powered by Capital Market - Live News

Volumes jump at Repco Home Finance counter
Sep 29,2016

Repco Home Finance clocked volume of 2.33 lakh shares by 13:55 IST on BSE, a 53.76-times surge over two-week average daily volume of 4,000 shares. The stock fell 1.95% to Rs 802.45.

Solar Industries India notched up volume of 1.06 lakh shares, a 37.30-fold surge over two-week average daily volume of 3,000 shares. The stock fell 1.46% to Rs 638.

Emami saw volume of 2.30 lakh shares, a 24.55-fold surge over two-week average daily volume of 9,000 shares. The stock shed 0.49% to Rs 1,164.95.

Gloster clocked volume of 1.30 lakh shares, a 20.47-fold surge over two-week average daily volume of 6,000 shares. The stock rose 9.96% to Rs 466.95.

Cheviot Company saw volume of 1.02 lakh shares, a 19.36-fold rise over two-week average daily volume of 5,000 shares. The stock rose 5.63% to Rs 1,025.

Powered by Capital Market - Live News

Marksans Pharma corrects on profit booking
Sep 29,2016

Meanwhile, the BSE Sensex was down 258.27 points, or 0.91%, to 28,034.54.

On BSE, so far 32.43 lakh shares were traded in the counter, compared with average daily volume of 8.53 lakh shares in the past one quarter. The stock hit a high of Rs 56.65 and a low of Rs 48 so far during the day. The stock hit a 52-week high of Rs 113.80 on 28 December 2015. The stock hit a 52-week low of Rs 33.45 on 1 March 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, 32.93% compared with 0.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, 15.34% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 40.93 crore. Face value per share is Re 1.

Shares of Marksans Pharma rose 14.73% in three trading sessions to settle at Rs 54.90 yesterday, 28 September 2016, from its close of Rs 47.85 on Friday, 23 September 2016.

The recent rally in shares of Marksans Pharma was triggered by the company announcing during market hours on Monday , 26 September 2016, that US Food and Drug Administration (USFDA) has granted approval to the company for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filled capsules 10 mg. Loratadine liquid filled capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC. Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching and other allergy symptoms.

Shares of Marksans Pharma spurted 10.76% to settle at Rs 53 on Monday, 26 September 2016.

Marksans Pharmas consolidated net profit fell 96.76% to Rs 1.02 crore on 11.14% fall in net sales to Rs 186.75 crore in Q1 June 2016 over Q1 June 2015.

Marksans Pharma is engaged in research, manufacturing and marketing of generic pharmaceutical formulation in the global market.

Powered by Capital Market - Live News

United Breweries (Holdings) hits roof after robust Q1 results
Sep 29,2016

The result was announced after market hours yesterday, 28 September 2016.

Meanwhile, the BSE Sensex was down 2.59 points, or 0.01%, to 28,290.22.

On BSE, so far 9.37 lakh shares were traded in the counter, compared with average daily volume of 1.68 lakh shares in the past one quarter. The stock hit a low of Rs 44.65 in intraday trade. The stock hit a 52-week high of Rs 48.70 on 20 September 2016. The stock hit a 52-week low of Rs 18.10 on 30 May 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 43.99% compared with 0.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 79.92% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 66.82 crore. Face value per share is Rs 10.

United Breweries (Holdings) is the flagship holding company of the UB Group, through which the promoters and the promoter group hold their stakes in the various companies which comprise the UB Group.

Powered by Capital Market - Live News

Wockhardt gains after UK MHRA completes inspection of Chikalthana plant
Sep 29,2016

The announcement was made during trading hours today, 29 September 2016.

Meanwhile, the BSE Sensex was up 58.98 points, or 0.21%, to 28,351.79.

On BSE, so far 5.92 lakh shares were traded in the counter, compared with average daily volume of 3.17 lakh shares in the past one quarter. The stock hit a high of Rs 945 and a low of Rs 903 so far during the day. The stock hit a 52-week high of Rs 1,748.20 on 2 December 2015. The stock hit a 52-week low of Rs 706.35 on 12 February 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 9.16% compared with 0.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 2.90% as against Sensexs 4.79% rise.

The large-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.

Wockhardt announced that inspection of the companys manufacturing unit at L-1, Chikalthana, Aurangabad, Maharashtra by UK Medicines and Healthcare products Regulatory Agency (MHRA) has since been completed without any critical observations and the approval status of the said unit continues.

On a consolidated basis, Wockhardts net profit slumped 82.65% to Rs 15.89 crore on 6.57% decline in net sales to Rs 1064.01 crore in Q1 June 2016 over Q1 June 2015.

Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.

Powered by Capital Market - Live News

CEAT advances as Amansa Holding Pte hikes stake
Sep 29,2016

The company made the announcement after trading hours yesterday, 28 September 2016.

Meanwhile, the S&P BSE Sensex, was currently up 74.14 points or 0.26% at 28,366.95

On BSE, so far 2.03 lakh shares were traded in the counter, compared with average daily volume of 1.16 lakh shares in the past one quarter. The stock hit a high of Rs 1,310 and low of Rs 1,263.90 so far during the trading session. The stock had hit record high of Rs 1,318.30 on 7 October 2015. The stock had hit 52-week low of Rs 731.20 on 24 June 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 38.48% compared with 0.18% rise in the Sensex. The scrip had outperformed the market in past one quarter, gaining 48.43% as against Sensexs 4.79% rise.

The mid-cap company has equity capital of Rs 40.45 crore. Face value per share is Rs 10.

Amansa Holding Pte bought 4.75 lakh shares or 1.17% stake in CEAT through secondary market purchase. After the latest stake buy, Amansa Holding Ptes stake in CEAT rose to 5.19%.

CEATs consolidated net profit fell 14.5% to Rs 104.06 crore on 4.04% increase in net sales to Rs 1460.92 crore in Q1 June 2016 over Q1 June 2015.

CEAT is one of Indias leading tyre manufacturers. The company sells its tyres under the CEAT brand.

Powered by Capital Market - Live News

Hindustan Copper declines as OFS for selling govts stake commences
Sep 29,2016

The announcement was made after market hours yesterday, 28 September 2016.

Meanwhile, the BSE Sensex was up 71.68 points, or 0.25%, to 28,364.49.

On BSE, so far 1.37 lakh shares were traded in the counter, compared with average daily volume of 1.76 lakh shares in the past one quarter. The stock hit a high of Rs 63.40 and a low of Rs 62.50 so far during the day. The stock hit a 52-week high of Rs 73.60 on 22 August 2016. The stock hit a 52-week low of Rs 42.30 on 19 February 2016. The stock had underperformed the market over the past 30 days till 28 September 2016, rising 0.15% compared with 0.18% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 22.72% as against Sensexs 4.79% rise.

The mid-cap company has equity capital of Rs 462.61 crore. Face value per share is Rs 5.

The government is offering a 7% stake in the company through a two-day offer for sale (OFS) beginning today, 29 September 2016. The government has set a floor price of Rs 62 per share, a 5.12% discount to the stocks Wednesdays closing share price of Rs 65.35 on BSE.

While the trading window is open for non-institutional investors today, 29 September 2016, retail investors can subscribe tomorrow, 30 September 2016. Retail investors will be allocated shares at a 5% discount to the cut-off price, the company said.

As at 11:15 IST, the OFS received bids for a total of 1.75 crore shares from non-retail investors as against 5.18 crore shares on offer for this category of investors.

The OFS, comprising 6.47 crore shares, will help the government raise Rs 401.54 crore. The governments stake will decline to 82.95% following the sale. The Government of India holds 89.95% stake in Hindustan Copper (as per shareholding pattern as on 30 June 2016).

Hindustan Copper reported net loss of Rs 2.88 crore in Q1 June 2016 as against net profit of Rs 20 crore in Q1 June 2015. Net sales declined 12.2% to Rs 205.99 crore in Q1 June 2016 over Q1 June 2015.

Hindustan Copper is a vertically integrated copper producing company encompassing mining, beneficiation, smelting, refining and casting of refined copper metal.

Powered by Capital Market - Live News

Marathon Nextgen Realty gains as shares begin trading on NSE
Sep 29,2016

Meanwhile, the S&P BSE Sensex was up 73.04 points, or 0.26% to 28,365.85

On BSE, so far 4,713 shares were traded in the counter as against an average daily volume of 10,383 shares in the past one quarter. The stock hit a high of Rs 279 and a low of Rs 262.35 so far during the day. The stock had hit a 52-week high of Rs 297 on 12 August 2016. The stock had hit 52-week low of Rs 107.10 on 30 September 2015. The stock had underperformed the market over the past 30 days till 28 September 2016, falling 4.87% compared with 0.18% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 20.86% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 28.44 crore. Face value per share is Rs 10.

Shares of Marathon Nextgen Realty had gained 10.06% to settle at Rs 263.65 yesterday, 28 September 2016 after the company said that shares of the company will be listed and admitted to dealings on the National Stock Exchange of India with effect from 29 September 2016. The announcement was made during market hours on 28 September 2016.

Marathon Nextgen Realtys consolidated net profit rose 60.11% to Rs 15.05 crore on 86.61% rise in total income to Rs 24.39 crore in Q1 June 2016 over Q1 June 2015.

Marathon Nextgen Realty is a Mumbai-based company engaged in real estate development business.

Powered by Capital Market - Live News

ICICI Prudential Life Insurance Company slips on debut
Sep 29,2016

The stock debuted at Rs 329, a discount of 1.50% to the initial public offer (IPO) price. So far the stock hit a high of Rs 333.90 and low of Rs 315.65. On BSE, so far 39.79 lakh shares were traded on the counter.

ICICI Prudential Life Insurance Company had priced the IPO at the top end of the Rs 300 to Rs 334 price band. The bidding for the IPO concluded on 21 September 2016. The issue received bids for 138.77 crore shares and it was subscribed 10.48 times.

The IPO comprised sale of up to 18.13 crore equity shares of ICICI Prudential, representing about 12.63% of its equity share capital for cash, through an offer for sale (OFS) by ICICI Bank. The entire proceeds from the OFS was paid to ICICI Bank.

Ahead of the IPO, ICICI Prudential raised Rs 1635.33 crore by selling 4.89 crore shares to 38 anchor investors. The shares were allotted to the anchor investors at Rs 334 per share, the top end of the Rs 300 to Rs 334 per share price band for the IPO. Anchor investors allotted shares of ICICI Prudential included Morgan Stanley Mauritius Company, Government of Singapore, UTI Trustee Co, SBI Trustee Co, Birla Sun Life Trustee Company among others.

ICICI Prudential is the largest private sector life insurer in India by total premium and assets under management at 31 March 2016. ICICI Prudential is a joint venture between ICICI Bank and Prudential Corporation Holdings, a part of the Prudential Group, an international financial services group. The company is one of the first private sector life insurance companies in India. It commenced operations in October 2000 and offers a range of life insurance, health insurance and pension products and services.

Powered by Capital Market - Live News

Panacea Biotec gains after announcing shortage of Cilamin 250 Capsule
Sep 29,2016

The announcement was made after market hours yesterday, 28 September 2016.

Meanwhile, the BSE Sensex was up 100.83 points, or 0.36%, to 28,393.64.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 18,653 shares in the past one quarter. The stock hit a high of Rs 124 and a low of Rs 118.25 so far during the day. The stock hit a 52-week high of Rs 171.20 on 4 December 2015. The stock hit a 52-week low of Rs 83.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 7.29% compared with 0.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 6.44% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Re 1.

Panacea Biotec said Cilamin 250 Capsule, used for treatment of Wilsons disease, Rheumatoid Arthritis and other conditions, witnessed short supply in the market during the last few months due to non-availability of raw material D-Penicillamine in India. Panacea Biotec said that its brand Cilamin 250 Capsules has been made available in limited quantities in the retail market. The temporary shortage is due to sudden disruption of supplies of raw material by qualified supplier beyond the control of the company. Since then company has been working tirelessly with alternate suppliers for supply of this raw material. Due to continuous efforts, the company has resumed limited production of Cilamin 250 and have released limited quantities in the market from 26 September 2016 from the companys manufacturing facility at Baddi under Good Manufacturing Practices.

The firm said it continues to work closely with existing and potential new raw material suppliers in China and India for access to the raw material in an accelerated manner. The company said it is in touch with Drug Controller General of India office for allowing imports of raw material in parallel to registration process under this emergency situation to ensure continuous access of this medicine to patients while other alternative sources in India are being also worked upon in an aggressive manner. As per current estimates, the company expects additional 2-4 weeks for access to additional quantities of raw material and additional 4 weeks for Cilamin 250 supplies to normalize.

Panacea Biotec said it is committed to do what all it takes to ensure continuous and sustainable access of good quality Cilamin 250 a critical lifesaving drug to patients.

Panacea Biotec reported net loss of Rs 19.67 crore in Q1 June 2016 as against net loss of Rs 36.90 crore in Q1 June 2015. Net sales declined 0.3% to Rs 120.40 crore in Q1 June 2016 over Q1 June 2015.

Panacea Biotec is one of Indias leading research based biotechnology company established research, manufacturing and marketing capabilities. Panacea Biotec is one of the largest vaccine producer in India and has been amongst the top 3 biotechnology companies and the top 50 pharmaceutical companies in India.

Powered by Capital Market - Live News